DutchNews.nl - DutchNews.nl brings daily news from The Netherlands in English

21 June 2025
Newsletter Donate Advertise
  • News
  • Life in the Netherlands
  • Jobs
  • Podcast
  • About us
  • Search
  • Home
  • Economy
  • Politics
  • Art and culture
  • Sport
  • Europe
  • Society
  • Environment
  • Health
  • Housing
  • Education
  • News
    • Home
    • Economy
    • Politics
    • Art and culture
    • Sport
    • Europe
    • Society
    • Environment
    • Health
    • Housing
    • Education
  • Life in the Netherlands
    • Latest
    • Opinion
    • Books
    • Travel
    • 10 Questions
    • Learning Dutch
    • Inburgering with DN
    • Food & Drink
    • Ask us anything
  • Jobs
  • Podcast
  • About us
    • Team
    • Donate
    • Advertise
    • Writing for Dutch News
    • Contact us
    • Privacy
    • Newsletter
  • Search

Experimental treatment ‘drastically’ improves prospects for worst Covid patients

July 21, 2020
Illustration: Depositphotos.com
Illustration: Depositphotos.com

An anti-inflammatory drug used in a Dutch hospital to treat the most seriously ill Covid-19 patients has been found to reduce the death rate by 65%.

The Zuyderland Medisch Centrum in Geleen and Heerlen used corticosteroids, sometimes in combination with other medicines to suppress the immune system, to treat patients who developed cytokine storm syndrome (CSS).

Around a quarter of Covid-19 patients who are admitted to hospital develop CSS, which occurs when the virus activates large numbers of white blood cells.

Patients who were treated with an intensive course of glucocorticoids were 65% less likely to die and 71% less likely to need mechanical ventilation, according to the findings published on Tuesday in The Annals of Rheumatic Disease.

At the beginning of the outbreak in March, 48% of Covid-19 patients being treated for CSS in the Limburg hospital died, but after doctors began using the steroid treatment the death rate fell to 16%.

Patients were given the treatment for between five and seven days, in combination with the immunosuppressant drug tocilizumab if no improvement was seen by the second day.

 

Share this article
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Copy URL
Uncategorized
Thank you for donating to DutchNews.nl.

We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.

Make a donation
Latest
Show more
Closures, diversions and delays: busy days on the roads ahead
Scorching start to summer: Events adjust plans to cope with heat
Beautiful addiction: art meets taxidermy in new Amsterdam museum
MPs agree to press ahead with most draft legislation
Minority suspects more likely to face jail "due to ethnic bias"
NewsHomeEconomyPoliticsArt and cultureSportEuropeSocietyEnvironmentHealthHousingEducation
Life in the NetherlandsLatestOpinionBooksTravel10 QuestionsLearning DutchInburgering with DNFood & DrinkAsk us anything
About usTeamDonateAdvertiseWriting for Dutch NewsContact usPrivacyNewsletter
© 2025 DutchNews | Cookie settings

Help us to keep providing you information about coronavirus in the Netherlands.

Many thanks to everyone who has donated to DutchNews.nl in recent days!

We could not provide this service without you. If you have not yet made a contribution, you can do so here.

The DutchNews.nl team

Donate now

Dutchnews Survey

Please help us making DutchNews.nl a better read by taking part in a short survey.

Take part now